End-of-day quote
Shenzhen S.E.
23:00:00 23/05/2024 BST
|
5-day change
|
1st Jan Change
|
25.18
CNY
|
+1.70%
|
|
+6.24%
|
-10.55%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
4,248
|
3,956
|
4,495
|
4,020
|
-
|
Enterprise Value (EV)
1 |
4,248
|
3,956
|
4,495
|
4,020
|
4,020
|
P/E ratio
|
24.7
x
|
18.6
x
|
19.8
x
|
14.1
x
|
12
x
|
Yield
|
-
|
1.55%
|
1.78%
|
2.12%
|
2.32%
|
Capitalization / Revenue
|
-
|
1.53
x
|
2.36
x
|
2.65
x
|
2.21
x
|
EV / Revenue
|
-
|
1.53
x
|
2.36
x
|
2.65
x
|
2.21
x
|
EV / EBITDA
|
-
|
16.3
x
|
15.3
x
|
10.7
x
|
9.18
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
2.67
x
|
2.67
x
|
2.15
x
|
1.89
x
|
Nbr of stocks (in thousands)
|
156,562
|
159,207
|
159,675
|
159,643
|
-
|
Reference price
2 |
27.14
|
24.85
|
28.15
|
25.18
|
25.18
|
Announcement Date
|
18/04/22
|
17/04/23
|
22/04/24
|
-
|
-
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
-
|
2,579
|
1,901
|
1,519
|
1,822
|
EBITDA
1 |
-
|
242.4
|
293.3
|
375
|
438
|
EBIT
1 |
-
|
240.1
|
255.3
|
331.5
|
392
|
Operating Margin
|
-
|
9.31%
|
13.43%
|
21.82%
|
21.52%
|
Earnings before Tax (EBT)
1 |
-
|
239.8
|
257.4
|
332
|
392
|
Net income
1 |
172.2
|
209.6
|
226.7
|
284.5
|
335.5
|
Net margin
|
-
|
8.13%
|
11.93%
|
18.73%
|
18.42%
|
EPS
2 |
1.101
|
1.338
|
1.420
|
1.780
|
2.105
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
0.3846
|
0.5000
|
0.5350
|
0.5850
|
Announcement Date
|
18/04/22
|
17/04/23
|
22/04/24
|
-
|
-
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
15.1%
|
14.4%
|
15.7%
|
16.3%
|
ROA (Net income/ Total Assets)
|
-
|
11%
|
-
|
14.4%
|
14.9%
|
Assets
1 |
-
|
1,898
|
-
|
1,976
|
2,252
|
Book Value Per Share
2 |
-
|
9.300
|
10.60
|
11.70
|
13.30
|
Cash Flow per Share
2 |
-
|
1.260
|
1.280
|
2.520
|
2.400
|
Capex
1 |
-
|
246
|
197
|
50
|
50
|
Capex / Sales
|
-
|
9.54%
|
10.39%
|
3.29%
|
2.74%
|
Announcement Date
|
18/04/22
|
17/04/23
|
22/04/24
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| -10.55% | 546M | | +38.75% | 728B | | +33.05% | 603B | | -6.27% | 360B | | +18.59% | 332B | | +1.01% | 279B | | +16.00% | 244B | | +8.09% | 207B | | -5.77% | 205B | | +6.15% | 164B |
Other Pharmaceuticals
|